Squarepoint Ops LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$815,134
-71.6%
32,206
-63.9%
0.00%
-83.3%
Q1 2023$2,874,066
+80.9%
89,229
+3.7%
0.01%
+100.0%
Q4 2022$1,588,686
+214.0%
86,061
+359.0%
0.01%
+100.0%
Q3 2022$506,000
+7.7%
18,751
-44.9%
0.00%0.0%
Q2 2022$470,000
-28.4%
34,004
+1.1%
0.00%0.0%
Q1 2022$656,000
-27.4%
33,647
+10.5%
0.00%0.0%
Q2 2021$903,000
+221.4%
30,463
+202.6%
0.00%
+50.0%
Q1 2021$281,000
-53.3%
10,067
-58.0%
0.00%
-75.0%
Q3 2020$602,000
-57.8%
23,946
-59.0%
0.01%
-65.2%
Q2 2020$1,425,000
+229.1%
58,369
+99.4%
0.02%
+109.1%
Q1 2020$433,000
-38.4%
29,266
-32.5%
0.01%
+175.0%
Q4 2019$703,000
-19.7%
43,340
-35.8%
0.00%
-55.6%
Q2 2019$876,000
+102.3%
67,528
+146.0%
0.01%
+80.0%
Q1 2019$433,000
+69.8%
27,446
+117.0%
0.01%
+66.7%
Q4 2018$255,000
-42.6%
12,647
-29.2%
0.00%
-40.0%
Q3 2018$444,000
-15.9%
17,868
+4.3%
0.01%
-37.5%
Q1 2018$528,000
-54.1%
17,130
-46.8%
0.01%
-60.0%
Q4 2017$1,151,00032,1910.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders